Pharmaceutical Executive podkast

Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million

0:00
2:27
Do tyłu o 15 sekund
Do przodu o 15 sekund
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.

Więcej odcinków z kanału "Pharmaceutical Executive"